GGrantIndex
← Leaderboards

Daniel J. Moore

Vanderbilt University

$2,401,640
Attributed
$2,401,640
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $625K · FY200825
$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$2,401,640 · 8

By mechanism

R21$861,376 · 2
R01$625,035 · 2
K08$433,800 · 1
R56$173,000 · 1
R03$156,000 · 1
F32$152,429 · 1

Top collaborators

No co-investigators on record.

Most similar at Vanderbilt University

Same institution · by research overlap

Others in their field

Top investigators on “Mediating

Research focus

MediatingInsulin-Dependent Diabetes MellitusIsletPreventCellsImmuneBeta CellT-LymphocyteInsulinInbred Nod MiceInnovationChildImmune ToleranceAutoimmune DiseasesDiabetes MellitusB-LymphocytesSignal TransductionAmericanAutoimmune ProcessImmunityImmune SystemCell PhysiologyFunctional DisorderAutoimmunity

Grant awards (15)

Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes$339,060
R01 · FY2025 · DK · contact PI
Optimizing Stage 2 T1DM Management: Assessing the Impact of GLP-1Ra on Metabolic Outcomes in Patients Receiving Teplizumab$285,975
R01 · FY2025 · DK · contact PI
Disruption of Treg-dependent Tolerance by B lymphocytes in Islet Transplantation$173,000
R56 · FY2021 · DK · contact PI
The Contribution of B Lymphocyte to T1D Reversal by Imatinib$197,500
R21 · FY2017 · AI · contact PI
The Contribution of B Lymphocyte to T1D Reversal by Imatinib$237,000
R21 · FY2016 · AI · contact PI
High Throughput Identification of Treg Activating Molecules$194,600
R21 · FY2016 · AI · contact PI
High Throughput Identification of Treg Activating Molecules$232,276
R21 · FY2015 · AI · contact PI
Restoration of Immune Tolerance in Type 1 Diabetes$78,000
R03 · FY2014 · DK · contact PI
Harnessing B lymphocytes as Antigen-Specific Regulators of Islet Tolerance$144,600
K08 · FY2013 · DK · contact PI
Restoration of Immune Tolerance in Type 1 Diabetes$78,000
R03 · FY2013 · DK · contact PI
Harnessing B lymphocytes as Antigen-Specific Regulators of Islet Tolerance$144,600
K08 · FY2012 · DK · contact PI
Harnessing B lymphocytes as Antigen-Specific Regulators of Islet Tolerance$144,600
K08 · FY2011 · DK · contact PI
Intracellular Targeting of Proinflammatory Pathways to Ameliorate Type 1 Diabetes$40,393
F32 · FY2010 · DK · contact PI
Intracellular Targeting of Proinflammatory Pathways to Ameliorate Type 1 Diabetes$57,194
F32 · FY2009 · DK · contact PI
Intracellular Targeting of Proinflammatory Pathways to Ameliorate Type 1 Diabetes$54,842
F32 · FY2008 · DK · contact PI